PIM1 and neoplasm: Selective inhibition of PIM1 leads to defective fatty acid metabolism, which abolishes the immunosuppressive phenotype of tumor-infiltrating myeloid cells and promotes the effector function of anti-tumor CD8 T cells (Xin et al., 2021).